<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03139786</url>
  </required_header>
  <id_info>
    <org_study_id>PI2012_843_0014</org_study_id>
    <nct_id>NCT03139786</nct_id>
  </id_info>
  <brief_title>Follow-up of a Cohort of Patients With Aortic Valve Bicuspidia</brief_title>
  <official_title>Prospective Follow-up of a Cohort of Patients With Aortic Valve Bicuspidia: Multicentre Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire, Amiens</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire, Amiens</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aortic valve bicuspidia (BVA) is a congenital condition corresponding to the presence of
      2 sigmoids instead of 3. This is the most common cardiac congenital anomaly affecting 0.5 to
      2% of the population The general rule. BVA may be associated with structural damage to the
      ascending aorta, which exposes BVA patients to a risk of developing ascending aortic aneurysm
      and acute aortic accidents. Recent data from the literature have revealed that the natural
      history of BVA is marked by a possible development towards significant valvulopathy and / or
      an ascending aortic aneurysm often requiring surgical treatment. However, the natural history
      of bicuspid disease remains poorly understood and the prognostic factors for progression to
      severe valvulopathy and / or aneurysmal dilatation of the ascending aorta remain to be
      determined.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 14, 2011</start_date>
  <completion_date type="Anticipated">October 14, 2021</completion_date>
  <primary_completion_date type="Anticipated">October 14, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Analysis of 10 year mortality in cardiac surgery in a patient with bicuspid</measure>
    <time_frame>10 years</time_frame>
    <description>Analyzing the natural history of Bicuspidia</description>
  </primary_outcome>
  <enrollment type="Anticipated">232</enrollment>
  <condition>Aortic Valve, Bicuspid</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Study the natural history of bicuspid</intervention_name>
    <description>Study the natural history of bicuspid</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with aortic bicuspidia examined in the echocardiography laboratory at one of the
        participating centers will be systematically eligible to participate in the study
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All patients examined in the echocardiography laboratory whose objective examination
             was a bicuspid valve of the aortic valve

          -  Bicuspidia may be formerly known

        Exclusion Criteria:

          -  Refusal to participate

          -  Patients who had already undergone bicuspid surgery or ascending aorta before being
             examined at the echocardiography laboratory
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Christophe TRIBOUILLOY, PhD</last_name>
    <phone>+33322455885</phone>
    <email>tribouilloy.christophe@chu-amiens.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>CHU Amiens Picardie</name>
      <address>
        <city>Amiens</city>
        <state>Picardie</state>
        <zip>80054</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christophe TRIBOUILLOY, PhD</last_name>
      <phone>+33322455885</phone>
      <email>tribouilloy.christophe@chu-amiens.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>May 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 10, 2017</study_first_submitted>
  <study_first_submitted_qc>May 2, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">May 4, 2017</study_first_posted>
  <last_update_submitted>May 2, 2017</last_update_submitted>
  <last_update_submitted_qc>May 2, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 4, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

